Table 2.
Patient demographics.
| Patient | Age | Sex | Diagnosis | Tumor Volume (cm3) | Plasma collection post 5-ALA dosing (hours) | Intraoperative Fluorescence | Fold Change Post/Pre 5-ALA |
|---|---|---|---|---|---|---|---|
| PI | 55 | M | Glioblastoma | 37.7 | 3 | Avidly fluorescent | 3.1 |
| P2 | 72 | F | Glioblastoma | 28.8 | 3.5 | Avidly fluorescent | 2.3 |
| P3 | 63 | M | Glioblastoma | 9.23 | 3 | Avidly fluorescent | 2.0 |
| P4 | 73 | M | Glioblastoma | 2.53 | 3 | Avidly fluorescent | 1.6 |
| P5 | 42 | F | Glioblastoma | 18.1 | 5 | Minimally fluorescent | 0.6 |
| P6 | 51 | M | Glioblastoma | 21.2 | 2 | Minimally fluorescent | 0.9 |
N/A = Not applicable.